Integrative epigenetic taxonomy of primary prostate cancer-Reference-Cited by-同舟云学术

Integrative epigenetic taxonomy of primary prostate cancer

Published:2018-11-21 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Stelloo Suzan,Nevedomskaya Ekaterina,Kim Yongsoo,Schuurman Karianne,Valle-Encinas Eider,Lobo João^ORCID,Krijgsman Oscar,Peeper Daniel Simon,Chang Seiwon Laura,Feng Felix Yi-Chung,Wessels Lodewyk Frederik Ary,Henrique Rui^ORCID,Jerónimo Carmen^ORCID,Bergman Andries Marinus,Zwart Wilbert

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-07270-2.pdf

Reference52 articles.

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386 (2015).

2. Mottet, N. et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 71, 618–629 (2017).

3. Roehl, K. A., Han, M., Ramos, C. G., Antenor, J. A. & Catalona, W. J. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J. Urol. 172, 910–914 (2004).

4. Varambally, S. et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393–406 (2005).

5. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11–22 (2010).

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer;Cancer Research Communications;2024-09-01

2. Machine learning based androgen receptor regulatory gene-related random forest survival model for precise treatment decision in prostate cancer;Heliyon;2024-09

3. Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer;Nature Communications;2024-08-06

4. Implications of noncoding regulatory functions in the development of insulinomas;Cell Genomics;2024-08

5. Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis prediction;Cell Reports Medicine;2024-08